Additive and Antagonistic Effects Among Combination of Agonists of Peroxisome Proliferator-Activated Receptor gamma (PPARg) on Transcriptional Activity
Journal Title: Diabetes Research – Open Journal - Year 2015, Vol 1, Issue 2
Abstract
Objective: The Angiotensin-II receptor blocker telmisartan and sulfonylurea glimepiride may have clinical usefulness as partial agonists of PPARg. We investigated additive and antagonistic effects among combinations of telmisartan, glimepiride, and the Thiazolidinedione (TZD) selective PPARg agonist pioglitazone on transcriptional activity of PPARg. Materials/Methods: The receptors of pCMX-PPARg and pCMX-RXR, and PPRE-Luc reporter gene were transfected into CV1 cells, and treated with following agents, and luciferace assay was performed. Moreover, mammalian two-hybrid assay was done using GAL4 responsive reporter tk-MH100(UAS)×4-Luc and the chimeric receptor GAL4-PPARg. Results: Telmisartan increased transactivation of PPARg dose dependently. Activation by telmisartan 10 µM was 58.8% of that by pioglitazone 10 µM. Glimepiride also increased transactivation of PPARg dose dependently. Activation by glimepiride 10 µM was 49.8% of that by pioglitazone 10 µM. Addition of telmisartan 5 µM significantly enhanced transactivation by glimepiride 10 and 50 µM. Moreover, addition of pioglitazone 0.5 µM significantly enhanced transactivation by glimepiride 10 and 50 µM. Mammalian two-hybrid assay showed additive effect between glimepiride and telmisartan on binding of SRC-1 to PPARg. On the other hand, addition of glimepiride 10 and 50 µM reduced transactivation by pioglitazone 5 µM to 74% and 70%, respectively. Conclusion: Partial agonists of PPARg additively enhanced transactivation by other agonists, whereas high concentration of partial agonists reduced transactivation by full agonist antagonistically.
Authors and Affiliations
Daisuke Tsuriya
Keywords
Related Articles
- EP ID EP550007
- DOI 10.17140/DROJ-1-105
- Views 145
- Downloads 0
Wellness Fasting and Hyperketosis
Ketoacidosis is sometimes a lethal complication of diabetes mellitus.1-3 Ketone bodies are considered to be the toxic elements of ketoacidosis. Wilder3 considered that the threshold of ketogenesis (i.e. the maximal rati...
Do we Need New Therapies for Diabetes?
Diabetes research and practice cluster (drug developers, payers, regulators and physicians) often (and especially in recent times) question the need of new therapies. Why would we need new therapies nowadays, when we hav...
Changes of Fat Volume and Adipocytokines by the Randomized Intervention Program for Obesity Control Program (SCOP)
Adipocytokines are bioactive substances synthesized and secreted by fat cell. Previous studies have reported an association between weight loss and adipocytokines. However, these studies are inconsistent and they have no...
Associations of Waist-to-Height Ratio withVarious Emotional and Irregular Eating, andMaking Environment to Promote Eating in Japanese Adults: The Saku Cohort Study
Objective: The waist-to-height ratio (WHtR) has started gaining attention as a measure of abdominal obesity. While the associations between various eating behaviors and high BMI or obesity or overweight determined by BMI...
Publishing Research: From an Occupational Therapy Perspective
Two years ago, at the inception of this Diabetes Research – Open Journal, I wrote an opinion article for the inaugural issue about the need for articles targeting secondary prevention.1 The journal has grown to provide m...